ZA949537B - 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds and also processes and intermediates for their preparation and medicaments containing these compounds - Google Patents

3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds and also processes and intermediates for their preparation and medicaments containing these compounds

Info

Publication number
ZA949537B
ZA949537B ZA949537A ZA949537A ZA949537B ZA 949537 B ZA949537 B ZA 949537B ZA 949537 A ZA949537 A ZA 949537A ZA 949537 A ZA949537 A ZA 949537A ZA 949537 B ZA949537 B ZA 949537B
Authority
ZA
South Africa
Prior art keywords
compounds
lower alkyl
phenylalkylaminoalkyloxy
intermediates
processes
Prior art date
Application number
ZA949537A
Other languages
English (en)
Inventor
Wolfgang Kehrbach
Michael Mlinaric
Dieter Ziegler
Reinhard Bruckner
Willi Bielenberg
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of ZA949537B publication Critical patent/ZA949537B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA949537A 1993-12-08 1994-11-30 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds and also processes and intermediates for their preparation and medicaments containing these compounds ZA949537B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341749A DE4341749A1 (de) 1993-12-08 1993-12-08 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ZA949537B true ZA949537B (en) 1995-08-11

Family

ID=6504420

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949537A ZA949537B (en) 1993-12-08 1994-11-30 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds and also processes and intermediates for their preparation and medicaments containing these compounds

Country Status (19)

Country Link
EP (1) EP0663395B1 (xx)
JP (1) JP3492433B2 (xx)
KR (1) KR950017965A (xx)
CN (1) CN1109051A (xx)
AT (1) ATE201200T1 (xx)
AU (1) AU7769494A (xx)
CA (1) CA2137446A1 (xx)
CZ (1) CZ303194A3 (xx)
DE (2) DE4341749A1 (xx)
ES (1) ES2156135T3 (xx)
FI (1) FI945750A (xx)
HU (1) HUT68518A (xx)
IL (1) IL111539A0 (xx)
NO (1) NO944722L (xx)
NZ (1) NZ264883A (xx)
PL (1) PL306155A1 (xx)
RU (1) RU94045839A (xx)
SK (1) SK150694A3 (xx)
ZA (1) ZA949537B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422708D0 (en) * 1994-11-10 1995-01-04 Zeneca Ltd Herbicides
FR2773153A1 (fr) * 1997-12-29 1999-07-02 Rhone Poulenc Agrochimie Nouveaux composes fongicides
EP1829873A1 (en) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrrazole derivatives as sigma receptors antagonists
EP1829866A1 (en) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1001161A (en) * 1972-05-05 1976-12-07 Burton K. Wasson 5-(3-substituted amino-2-hydroxypropoxy)1,3-disubstituted pyrazoles and method of preparation
DE2828529A1 (de) * 1978-06-29 1980-01-17 Kali Chemie Pharma Gmbh Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel
FR2479219A1 (fr) * 1980-04-01 1981-10-02 Nativelle Sa Ets Amino-alcoxy pyrazoles, procede pour leur preparation, et medicaments les contenant
FR2513996A1 (fr) * 1981-10-02 1983-04-08 Nativelle Sa Ets Derives du pyrazole, procede pour leur preparation et application en therapeutique
DE3424586A1 (de) * 1984-07-04 1986-01-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
HU9403458D0 (en) 1995-02-28
RU94045839A (ru) 1996-09-27
CZ303194A3 (en) 1995-08-16
DE4341749A1 (de) 1995-06-14
EP0663395A1 (de) 1995-07-19
SK150694A3 (en) 1995-07-11
DE59409756D1 (de) 2001-06-21
ES2156135T3 (es) 2001-06-16
NZ264883A (en) 1995-12-21
NO944722L (no) 1995-06-09
CA2137446A1 (en) 1995-06-09
ATE201200T1 (de) 2001-06-15
JPH07196622A (ja) 1995-08-01
NO944722D0 (no) 1994-12-07
HUT68518A (en) 1995-06-28
KR950017965A (ko) 1995-07-22
EP0663395B1 (de) 2001-05-16
PL306155A1 (en) 1995-06-12
AU7769494A (en) 1995-06-15
JP3492433B2 (ja) 2004-02-03
FI945750A0 (fi) 1994-12-07
CN1109051A (zh) 1995-09-27
IL111539A0 (en) 1995-01-24
FI945750A (fi) 1995-06-09

Similar Documents

Publication Publication Date Title
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
GR950300059T1 (en) Retroviral protease inhibiting compounds.
GB2210366B (en) Substituted cycloalkanols
TW198028B (xx)
IL118367A0 (en) Heteroaroyl derivatives
MY101126A (en) Novel compounds
ZA949537B (en) 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds and also processes and intermediates for their preparation and medicaments containing these compounds
FI904512A0 (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
GB9218113D0 (en) Pharmaceutical compounds
ES461779A1 (es) Procedimiento para la preparacion de lariloxi-3-amino-3-pro-panoles.
GR3020488T3 (en) Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
ES2099727T3 (es) 8-azabiciclo(3.2.1)octilalquiltiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES8604591A1 (es) Procedimiento para preparar nuevas 11-piperazinil-5h-imidazo(2,1-c)(1,4)-benzodiazepinas
GB9015485D0 (en) Heterocyclic derivatives
ES8801641A1 (es) Un procedimiento para la preparacion de derivados de beurazepina.
JO1621B1 (en) Therapeutic agents